Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs.
Cerenome stock last closed at $3.96, up 12.5% from the previous day, and has decreased 78.59% in one year. It has overperformed other stocks in the Medical Devices industry by 0.21 percentage points. Cerenome stock is currently +36.55% from its 52-week low of $2.90, and -83.15% from its 52-week high of $23.50.
At the moment, there are 6.88M CNSY shares outstanding. The market capitalization of CNSY is $27.26M. In the last 24 hours, 138,000 CNSY shares were traded.
How to Buy Cerenome Stock
Wondering how to invest in Cerenome stock? Here's how.
Decide where to buy Cerenome stock: You need to decide on an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you choose where to buy Cerenome stock.
Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Deposit funds into your brokerage account: Pick your method of payment and add your info.
Evaluate Cerenome stock: The Cerenome ticker symbol is CNSY. Is Cerenome stock a good investment? Should you buy shares of CNSY? How do CNSY's underlying business fundamentals look? Do top analysts think Cerenome is a good buy? Why has CNSY's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if CNSY is a good stock to buy).
Execute your CNSY trade: Decide if you will purchase CNSY shares at the current market price or use a limit order to purchase CNSY stock at a given price.
Get notifications regarding your CNSY investment: Create a watchlist to track your new investment in Cerenome stock.
Step 1: Decide where to buy Cerenome stock
You will need an online brokerage account in order to access the NASDAQ market and buy CNSY stock.
A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to global financial markets: From Technology to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've selected your brokerage, the next step is to fill out some personal details so you can invest in CNSY today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Cerenome stock
Once you have decided on the best place to buy Cerenome stock, it's very important to analyze their stock before you buy, so you truly comprehend the risk and upside.
Cerenome quick stats
CNSY Price
$3.96
1w %
5.32%
1y %
-78.59%
5y %
-99.45%
P/E
-2.55x
P/B
2.28x
P/S
5.08x
PEG
N/A
Revenue
$5.18M
Earnings
-$11.93M
Fore. Rev. Growth
103.37%
Fore. Earn. Growth
N/A
Market Cap
$27.26M
Next Earnings
Aug 13, 2026
Next Dividend
N/A
CNSY Fundamentals
WallStreetZen was designed to help part-time investors perform better fundamental analysis in less time.
Last year, CNSY revenue was $5.18M. In the last five year, CNSY's revenue has grown by 94.74% per year. This was faster than the Medical Devices industry average of 9.29%.
What are CNSY executives and large shareholders up to?
In the last year, insiders at CNSY have bought more shares than they have sold.
Andrew John Hugh Macintyre Sims, Chief Financial Officer of CNSY, was the latest CNSY insider to buy. They bought $10,200.00 worth of CNSY stock on Nov 4, 2025.
No, Cerenome doesn't provide an income stream by paying out dividends.
CNSY Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your CNSY trade
There are two main options:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are generally fine.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to be certain you're buying or selling at a given price, use a limit order.
Press the Open Trade button and eToro will place your order.
If you want more help investing in stocks on eToro, click the how to video below:
As of Aug 4, 2026, it costs $3.96 to buy one share of Cerenome stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.253 shares of CNSY.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.